Friday, October 9, 2020

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR) | Radiation Oncology | Full Text

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR) | Radiation Oncology | Full Text
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)